INDIUM-111 OCTREOTIDE SCAN

DATES (S) OF SERVICE: 10/03/05

PROCEDURE:  After IV injection of 111In-pentetreotide, images were acquired of the following views and at the following dates: [...]

VIEWS/DATES: Anterior and posterior projection views of upper body on [...] (4-hour post injection), [...] (24-hour) and [...] (48-hour).

RADIOPHARMACEUTICAL DOSES: [6] mCi

CORRELATIVE STUDIES: None

COMPARISON: None

CLINICAL HISTORY:  The patient is a [...]-year-old [fe]male patient with metastatic carcinoid tumor.

FINDINGS: 

The projection images demonstrate physiological tracer activity in the liver, spleen, bowel, bladder and both kidneys. 

Tracer activity in the liver and spleen is homogeneous.

 The spleen is enlarged. 

The delayed images (24 hours and 48 hours post-injection) show slightly increased nonspecific bowel activity. 

There is no focal increased or decreased tracer activity in the liver region to suggest intrahepatic lesions. 

There is no extrahepatic abnormal tracer activity. 

Multiple foci of increased tracer uptake are identified in the [...]. 

No other area of abnormal tracer activity is identified.

Normal physiological uptake is noted in the intestine, spleen, and both kidneys. 

CONCLUSIONS: 

1. Multiple foci of increased tracer activity in the liver are consistent with the known liver metastases. These foci are unchanged when compared to the prior study on [...].

2. Because of the high normal physiological uptake of tracer in the spleen the abnormality noted in the tail of the pancreas on the recent MRI is difficult to evaluate on the octreotide scan. Abnormal uptake in this region cannot be ruled out. 

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.